Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 18, 2014

View Archived Issues

Korean patent details novel mutant haptoglobins

Screening of circulating patient-derived breast cancer cells for tailored treatment

uniQure acquires InoCard

Janssen describes different series of FLAP inhibitors for inflammatory diseases

Novel glucocorticoid receptor agonists show selectivity for transrepression over transactivation

G2B Pharma receives financing and right to in-license nasal delivery technologies

Galenica lays foundation for two independent companies

The Michael J. Fox Foundation for Parkinson's Research updates on its Partnering Program

Carfilzomib fails to meet primary endpoint in phase III multiple myeloma trial

U.S. DTRA supports preclinical development of Evolva's GC-072 for acute melioidosis

Novel nontreponemal EIA assay for the diagnosis of syphilis

Actelion Pharmaceuticals discloses new P2X7 antagonists

University of Toledo patents novel anticancer agents

Neuraceq launched in U.S.

New metalloenzyme inhibitors designed by Viamet Pharmaceuticals

Novartis disclose novel p53-Mdm2 interaction inhibitors

Skyepharma acquires rights to inhaled therapy platform from Pulmagen

Ligand Pharmaceuticals signs Captisol license agreement with Avion Pharmaceuticals

FDA grants fast track designation to SPN-810

FDA grants fast track designation to AG-221 for acute myelogenous leukemia

Miltenyi Biotec acquires Lentigen's lentiviral vector business

Ablynx awarded grant supporting nanobody development for ocular applications

BioCryst receives additional NIAID funding to advance development of BCX-4430

FDA accepts Pfizer's rLP-2086 BLA for review and grants priority review status

FDA approves Avastin in combination with chemotherapy for advanced cervical cancer

Questcor Pharmaceuticals acquired by Mallinckrodt

FDA approves Plegridy for relapsing multiple sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...